Header Logo

Connection

NATHAN FOWLER to Neoplasms, Second Primary

Back to Details
This is a "connection" page, showing publications NATHAN FOWLER has written about Neoplasms, Second Primary.
NATHAN FOWLER
Connection Strength
0.113
Neoplasms, Second Primary
  1. Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma. J Clin Oncol. 2022 10 01; 40(28):3239-3245.
    View in: PubMed
    Score: 0.113
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.